• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number MA60BM
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
A sample device was not returned for analysis.Complaint history and product history record could not be reviewed because the reporting facility did not provide a valid lot number or any identification traceable to the manufacturing documentation.Root cause has not been identified.Literature citation: veshesh patel et.Al., intraocular lens exchange: indications, comparative outcomes by technique, and complications: clinical ophthalmology 23mar2023:17 941¿951.The manufacturer internal reference number is: (b)(4).
 
Event Description
An other health care professional published original article with a purpose to describe the indications, outcomes, and complications associated with intraocular lens (iol) exchange.Iol exchange was performed in 511 eyes of 489 patients (59.7% men; mean age: 67.0 ± 13.9 years, median time from cataract procedure to iol exchange: 47.5 months).Mean uncorrected visual acuity significantly improved from 20/192 snellen equivalent (logmar 0.981) preoperatively to 20/61 (logmar 0.487) at last follow-up (p < 0.001).Overall, 384 eyes (78.7%) met their desired refractive outcome within ±1.0 diopter (d).The study was concluded stating the iol exchange significantly improved uncorrected visual acuity and more than three-quarters of eyes met the refractive goal.Certain techniques were associated with complications, including subsequent dislocation associated with iris-sutured technique and iol tilt associated with yamane scleral-fixation technique.This information may help guide surgeons in deciding between procedural techniques for individual patients during iol exchange preoperative planning. this file is related to patient who had previous iol exchanged with company lens using iris-sutured technique with suture.The lens was exchanged in re-operation after 63 days from the initial exchange due to dislocation using 4-point scleral sutured technique.The lens was replaced with non company lens.There were 12 files associated with this file, this is 2 of 12 files.Literature citation: veshesh patel et.Al., intraocular lens exchange: indications, comparative outcomes by technique, and complications: clinical ophthalmology 23mar2023:17 941¿951.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF MULTIPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17069394
MDR Text Key316586641
Report Number1119421-2023-01030
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMA60BM
Device Catalogue NumberMA60BM.XXX
Device Lot NumberASKU
Was Device Available for Evaluation? No
Date Manufacturer Received05/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-